Related by context. All words. (Click for frequent words.) 66 viraemia 65 viremia 64 HBV DNA 64 HBeAg seroconversion 64 serum urate levels 63 virological response 63 hepatic fibrosis 63 virologic 63 parasitemia 63 serum HBV DNA 62 nephrotoxicity 62 serum testosterone 62 S. aureus colonization 62 posttreatment 62 intravascular hemolysis 62 lactate dehydrogenase 62 imatinib therapy 61 IL 1ß 61 nocturnal hypoglycemia 61 virologic suppression 61 thyroid carcinoma 61 perioperatively 61 Viral load 61 timepoints 61 imatinib resistance 61 HbF 61 glycated hemoglobin levels 61 genotypic resistance 61 plasma HCV RNA 61 HIV RNA 60 IFN γ 60 Natalizumab 60 NNRTI resistance 60 ovulatory 60 PASI scores 60 TNFalpha 60 detectable HCV RNA 60 serum cortisol 60 antibody titer 60 caspofungin 60 myocardial reperfusion 60 HBeAg 60 virological suppression 60 platelet reactivity 60 liver histology 60 hyperalgesia 60 hemodilution 60 sustained virological response 60 posttransplant 60 transgene expression 60 lymphocyte count 60 complete cytogenetic response 60 corticosteroid therapy 60 neutropenic 60 PSA nadir 59 lactate dehydrogenase LDH 59 lung metastasis 59 HER2 expression 59 CMV infection 59 adefovir 59 GnRH agonist 59 HSCT 59 APTIVUS r 59 serum HCV RNA 59 rhTSH 59 HBV infection 59 inducible nitric oxide synthase 59 type 1diabetes 59 acute GvHD 59 CIN3 59 locomotor activity 59 blood glucose concentrations 59 serum phosphate 59 bronchial inflammation 59 antibody mediated 59 inotropic 59 leukocytosis 59 nitrotyrosine 59 HER2 amplification 59 hemoglobin Hb 59 viral titers 59 fibrosis progression 59 alanine aminotransferase ALT 59 CsA 59 overt hypothyroidism 59 IFN beta 59 mg kg dose 59 intestinal permeability 59 HCV RNA 59 neutrophil counts 59 seropositive patients 59 ventricular tachyarrhythmia 59 virologically 59 virologic response 59 serum testosterone levels 59 lumbar spine BMD 59 vasoactive 59 alteplase 59 lymphopenia 59 virologic failure 59 growth hormone secretion 58 combination antiretroviral therapy 58 recurrent venous thromboembolism 58 hematologic toxicity 58 biochemical recurrence 58 Crohn Disease Activity 58 MS relapses 58 EDSS scores 58 epithelial barrier 58 HBV DNA levels 58 elevated transaminases 58 AZT zidovudine Retrovir 58 lupus anticoagulant 58 CR nPR 58 ALT flares 58 T2 lesion volume 58 KRAS mutant tumors 58 genital herpes infections 58 allograft rejection 58 virological failure 58 p# activation 58 elevated ALT 58 anti Xa 58 vasopressor 58 potentiation 58 IFN α 58 EXJADE 58 radiographic progression 58 tipranavir ritonavir 58 haematological toxicity 58 IFN gamma 58 anagrelide 58 diabetic kidney 58 serum estradiol 58 plasma pharmacokinetics 58 ALT normalization 58 genital ulcer disease 58 cervical lesions 58 Gleevec resistant 58 chlamydial 58 erythropoiesis 58 recurrent genital herpes 58 AGILECT R 58 antibody titers 58 p = NS 58 plasminogen activators 58 CMV infections 58 NMIBC 58 plasma creatinine 58 interferon γ 58 hypoperfusion 58 thrombocytopenic 58 retransplantation 58 ACTH 58 serum creatinine levels 58 aminotransferase ALT 58 systemic hypotension 57 severe rotavirus gastroenteritis 57 liver decompensation 57 systemic toxicity 57 Hematologic 57 prednisone prednisolone 57 intraocular pressure IOP 57 HbA 1c levels 57 liver metastasis 57 HBsAg 57 thrombotic complications 57 seropositivity 57 ovarian hormones 57 biochemical relapse 57 tipranavir r 57 rt PA 57 Ishak fibrosis score 57 frataxin 57 torsade de pointes 57 N. gonorrhoeae 57 antimicrobial prophylaxis 57 salivary flow 57 divalproex sodium 57 GnRH antagonist 57 LHRH agonists 57 pharmacokinetic interactions 57 relapsed MM 57 hematological parameters 57 parkinsonian symptoms 57 EGFR receptor 57 parasitaemia 57 endothelial activation 57 CMV reactivation 57 Decitabine 57 Hydroxyurea 57 INFERGEN 57 Hypotension 57 fulvestrant 57 moderate renal impairment 57 autoantibody levels 57 decitabine 57 transaminase elevations 57 pentoxifylline 57 intratumoral 57 HER2 overexpression 57 TNF α 57 interferon ribavirin 57 adrenal function 57 chloride secretion 57 bladder carcinoma 57 QTcF 57 neointimal hyperplasia 57 haematologic 57 MCyR 57 ALT elevation 57 pT3 57 inhibin 57 postoperative morbidity 57 cytomegalovirus infection 57 aPTT 57 perioperative complications 57 fibrin deposition 57 CD# upregulation 57 viral load 57 undetectable HBV DNA 57 agonist induced 57 clodronate 57 pegIFN 57 renal toxicity 57 anemia hemoglobin 57 LV ejection fraction 57 serum urate 57 isoenzyme 57 sotalol 57 endometrial carcinoma 57 NAbs 57 thrombocytosis 57 viral suppression 57 abacavir lamivudine 57 IOP lowering 57 indinavir 57 E selectin 57 deep venous thromboses 57 glomerular filtration 57 thyroglobulin 57 transaminase levels 57 cerebral ischemia 57 virologic breakthrough 57 serum aminotransferase levels 57 SSc 57 androgen deprivation 56 cardiovascular calcification 56 protease inhibitors PIs 56 log# reduction 56 fibrinolysis 56 thyrotropin 56 cis retinoic acid 56 allogeneic HSCT 56 amenorrhoea 56 pCR 56 FOXP3 56 triiodothyronine 56 intravascular volume 56 serum homocysteine 56 Akt activation 56 corrected QT interval 56 tumor regressions 56 androgen ablation 56 endotoxemia 56 EBV infection 56 P = .# 56 neutropenic patients 56 hypoxemia 56 #mg/day [001] 56 neurologic deficits 56 β blockers 56 neutralizing antibody 56 chemosensitivity 56 anti HBs 56 ispinesib administered 56 response CCyR 56 mycophenolate mofetil MMF 56 vasodilatation 56 dose dependently 56 mutated K ras 56 IV bisphosphonates 56 nonalcoholic steatohepatitis NASH 56 TMP SMX 56 antiandrogen 56 sustained virologic response 56 nephrotoxic 56 steroid dexamethasone 56 isoproterenol 56 hypoxia induced 56 lipoatrophy 56 tumor necrosis 56 TMC# r 56 myocardial fibrosis 56 corticosteroid dose 56 EGFR TKI 56 femoral neck fracture 56 hypersecretion 56 immunoreactivity 56 experienced virologic failure 56 primary aldosteronism 56 HIV HCV coinfected 56 TGF ß1 56 baseline LDH 56 tryptase 56 invasive aspergillosis 56 Kinoid 56 aminotransferase levels 56 anterior uveitis 56 #.#ng/ml 56 neurocognitive outcomes 56 hepatic insulin sensitivity 56 platelet activation 56 Virological 56 β blocker 56 neutrophil 56 beta adrenergic receptor 56 postoperative mortality 56 mcg BID 56 oral anticoagulation 56 tolterodine ER 56 coinfection 56 proinflammatory cytokine 56 TNF antagonist 56 detrusor 56 nelfinavir 56 NQO1 56 oral anticoagulant therapy 56 ERK activation 56 leukocyte counts 56 adrenal suppression 56 gonococcal 56 nicardipine 56 GI motility 56 mucosal inflammation 56 proteinuria 56 GHRH 56 alanine aminotransferase 56 eosinophil count 56 hemodynamic variables 56 perfusion abnormalities 56 ERalpha 56 #.#/#.# mm Hg [003] 56 lamivudine refractory patients 56 cranial irradiation 56 hepatorenal syndrome 56 calcineurin inhibitor 56 PSADT 56 Hb A1C 56 serum concentrations 56 AST ALT 56 selective modulator 56 serum potassium 56 PKC inhibitors 56 eculizumab therapy 56 autoregulation 56 pegaptanib 56 serum phosphate levels 56 K#N 56 PlGF 56 postoperative infections 56 CYP#D# genotype 56 lymphoproliferative disorder 56 immunological responses 56 serum thyroglobulin 56 eosinophilia 56 beta blocker therapy 56 vaginal flora 56 certolizumab 56 viral titer 56 cortisol secretion 56 Leydig cell 56 coagulopathy 56 LTB4 56 Postoperatively 56 akinesia 56 elevated IOP 56 ischaemia 56 androgen suppression 56 dosing frequency 55 parathyroid hormone PTH 55 hepatic toxicity 55 atheroma volume 55 cinacalcet 55 postoperative AF 55 Toxicities 55 rituximab Rituxan 55 serum albumin 55 plasma renin activity 55 proliferative diabetic retinopathy 55 SIV infection 55 bezafibrate 55 lamivudine resistant 55 suppressive therapy 55 mutated KRAS 55 ovarian carcinoma 55 circulating lymphocytes 55 peginterferon alfa 55 operable breast cancer 55 hematologic parameters 55 trimethoprim sulfamethoxazole 55 Chlamydia trachomatis infection 55 Clinically significant 55 macroalbuminuria 55 CD4 + cell 55 coronary stenoses 55 endothelium dependent 55 multivariate adjustment 55 prostate cancer CaP 55 SCr 55 CEACAM1 55 IFNg 55 rFVIIa 55 IGFBP 3 55 timepoint 55 clinicopathological features 55 Pred Forte 55 hemorrhagic complications 55 baroreflex 55 ciclosporin 55 prolonged QT interval 55 β cell 55 HAART 55 endometrial hyperplasia 55 cerebral vasospasm 55 vaso occlusive crisis 55 oxcarbazepine 55 achieved sustained virological 55 ALT AST 55 BMPR2 55 euthyroid 55 CCyR 55 CD4 + cells 55 paroxysmal AF 55 myeloablative 55 CHOP chemotherapy 55 aspartate aminotransferase AST 55 rapid virological response 55 abnormal cytology 55 CYP #A# 55 intraventricular 55 myeloperoxidase 55 recurrent VTE 55 inhaled iloprost 55 vWF 55 ADAMTS# 55 cytogenetic responses 55 HAART regimens 55 coadministration 55 hepatic encephalopathy HE 55 HuR 55 lymphocyte counts 55 receiving VICTRELIS 55 pamidronate 55 laxation 55 pimozide 55 hepatic enzymes 55 Thrombotic thromboembolic complications 55 hyperresponsiveness 55 4mg/kg 55 serum ALT 55 NNRTI resistant virus 55 CD4s 55 inflammatory cytokine 55 hypocalcaemia 55 hyperglycaemia 55 serum IGF 55 intact parathyroid hormone 55 intestinal mucosa 55 ischemia induced 55 M#V mutation 55 hypercapnia 55 rebleeding 55 perinatal transmission 55 adrenalectomy 55 LPS induced 55 postoperative complication 55 serum PTH 55 d4T stavudine Zerit 55 uM 55 serum bicarbonate 55 PANSS scores 55 H pylori 55 Flu Cy 55 dose cyclophosphamide 55 hepatic glucose production 55 undetectable viral 55 fibrinolytic 55 PGE2 55 ibandronate 55 hour bronchodilation 55 HPA axis suppression 55 overt nephropathy 55 specific antigen PSA 55 atazanavir ritonavir 55 undetectable HCV RNA 55 plasma uric acid 55 postoperative hemorrhage 55 serum sodium 55 subclinical inflammation 55 renal cysts 55 pulmonary inflammation 55 TURBT 55 hepatic function 55 paroxysmal supraventricular tachycardia 55 pyrimethamine 55 IGFBP 55 bacteriuria 55 LNG IUS 55 acromegalic patients 55 thyroid hormone levels 55 Ribavirin causes 55 preterm neonates 55 cytopenias 55 CD4 lymphocyte count 55 refractory ischemia 55 FOLFOX6 55 histologic subtype 55 steatohepatitis 55 neutrophil count 55 umbilical artery 55 hCG human chorionic 55 Aptivus ® 55 glucocorticoid hormones 55 antigen PSA levels 55 albumin excretion rate 55 BARACLUDE ® 55 IL 1β 55 antidiabetic medications 55 T2DM 55 digoxin toxicity 55 cervical intraepithelial neoplasia 55 neuromuscular blockade 55 chemoradiotherapy 55 Hb levels 55 perioperative mortality 55 reperfusion injury 55 vasospasm 55 aspartate aminotransferase 55 DFMO 55 dystrophin expression 55 cisplatin chemotherapy 55 lymphocytosis 55 serum uric acid 55 ribavirin RBV 55 coinfected 55 rhGH 55 microglial activation 55 postintervention 55 antiangiogenic therapy 54 nucleotide analog 54 fluticasone salmeterol 54 ileus 54 neutropenic fever 54 atelectasis 54 DHEA supplementation 54 neurologic sequelae 54 leukemic stem cells 54 systemic corticosteroid 54 gastrointestinal stromal tumors GIST 54 HER2/neu 54 B7 H3 54 aminotransferases 54 catecholamine 54 symptomatic intracranial 54 neurologic progression 54 azoospermia 54 F FDG PET 54 intravenous cyclophosphamide 54 radiosensitivity 54 SGPT 54 lung fibrosis 54 nonmetastatic 54 hypotensive 54 T1DM 54 leukocyte count 54 GH secretion 54 mediated immunity 54 collagen degradation 54 paraprotein 54 lymph node metastasis 54 adalimumab Humira 54 ischemic lesions 54 virologic responses 54 anastomotic leak 54 QTc interval 54 hypomagnesemia 54 vidofludimus 54 initiating antiretroviral therapy 54 plasminogen activator inhibitor 54 posaconazole 54 fluoroquinolone resistance 54 gonadotrophin releasing hormone 54 disease progression 54 achieved ACR# 54 menopausal symptom 54 BYSTOLIC 54 thromboembolic disease 54 virus HBV 54 ipsilateral stroke 54 baroreceptor 54 fulminant hepatic failure 54 cerebral ischemic 54 reinfarction 54 liver scarring 54 thromboembolic complications 54 Dasatinib 54 antiarrhythmic drugs 54 RNA copies mL 54 alkylating agent 54 hypofractionated radiation 54 pulmonary vascular 54 neurotrophic 54 ABCB1 54 endogenous EPO 54 urate levels 54 contractile function 54 NYHA functional class 54 neurodevelopmental impairment 54 basiliximab 54 antihypertensive therapy 54 HbA1C 54 colorectal adenoma 54 microvessel density 54 CMV disease 54 UPDRS scores 54 HBeAg negative patients 54 Adalimumab 54 SELENA SLEDAI 54 mRS 54 intravenous immunoglobulin IVIg 54 systolic dysfunction 54 ventilatory 54 FVIII 54 gastric adenocarcinoma 54 achieving PASI 54 heterozygotes 54 ORENCIA ® 54 viral kinetics 54 Ph + 54 chronic hepatitis cirrhosis 54 apneic episodes 54 PCa 54 allogeneic transplantation 54 olmesartan 54 Bcl xL 54 haematopoietic 54 clomipramine 54 HBV vaccine 54 antiretroviral naive 54 FUSILEV enhances 54 airway hyper responsiveness 54 left ventricular systolic 54 intima media thickness 54 transfusion transmitted 54 undetectable viral loads 54 opioid analgesia 54 chemo radiotherapy 54 bcr abl 54 glycosylated hemoglobin HbA1c 54 aromatase inhibitor therapy 54 hepatotoxicity 54 #q# deletion syndrome 54 morphological abnormalities 54 μmol L 54 MULTAQ 54 serum potassium levels 54 administered subcutaneously 54 glucose homeostasis 54 antiresorptive 54 piperacillin tazobactam 54 hepatitis B infection 54 bacterial translocation 54 CDAI 54 thromboembolic 54 Immunohistochemical analysis 54 antiandrogens 54 serum parathyroid hormone 54 durable remissions 54 intravenous bisphosphonates 54 PegIFN RBV 54 surgical debulking 54 leukocyte 54 neostigmine 54 antibiotic prophylaxis 54 methotrexate therapy 54 sUA levels 54 TOP2A gene 54 pharmacologic intervention 54 SCIg 54 INVEGA ® 54 pulmonary infiltrates 54 squamous cell lung cancer 54 troponin T 54 8mg/kg 54 morphometric vertebral fractures 54 genotype 1b 54 CDAI score 54 serum phosphorous 54 overt HE 54 epoetin beta 54 serum calcium 54 infliximab 54 extrapyramidal symptoms 54 serotonin reuptake 54 DAS# CRP 54 artery stenosis 54 experimentally induced 54 intrahepatic 54 sUA 54 H. pylori eradication 54 CIMZIA TM 54 coagulation abnormalities 54 atorvastatin #mg 54 IgG antibody 54 achieved CCyR 54 Ileus 54 mg TID 54 cerebral oxygenation 54 MMSE score 54 luteal 54 mg/m2 dose 54 pg ml 54 d4T 54 severe exacerbations 54 glycemia 54 dose cohort 54 seroconversion 54 YMRS 54 pyridostigmine 54 analgesic medications 54 HIV lipodystrophy 54 mutant KRAS 54 TroVax ® 54 tumoral 54 Pneumocystis carinii pneumonia 54 initiating HAART 54 atypical ductal hyperplasia 54 hemodynamic instability 54 retrograde ejaculation 54 rtPA 54 amprenavir 54 IFN alpha 54 Thrombocytopenia 54 ximelagatran 54 nocturnal hypoglycaemia 54 heparanase 54 sub maximal 54 polytherapy 54 HPV-#/# 54 metastatic malignant 54 PHPT 54 rechallenge 54 K ras mutations 54 hepatitis C genotype 54 intestinal motility 54 thyrotoxicosis 54 neurocognitive deficits 54 platelet counts 54 rituximab monotherapy 54 tolterodine 54 imatinib Gleevec 54 paricalcitol 54 ASCUS 54 periprocedural 54 thrombus formation 54 pyrazinamide 54 lichen planus 54 CIMZIA TM certolizumab pegol 54 protease inhibitor mutations 54 HDRS 54 sFlt 1 54 hemoglobin A1c levels 54 immuno suppression 54 potent antiretroviral therapy 54 eNOS 54 P selectin 54 invasive fungal infection 54 neonatal morbidity 54 genital ulcers 54 bone resorption 54 TNFα 54 hyperprolactinemia 54 CD8 T cell 54 ß amyloid 54 hemoglobin concentration 54 chronic HCV genotype 54 Clusterin 54 BCG refractory 54 haemolysis 54 HCV Genotype 54 sputum eosinophils 54 peginterferon 54 inhaled budesonide 54 Gag polymorphisms 54 immunosuppressive regimen 54 hypokalemia 54 somatostatin analogs 54 unboosted 54 tegaserod 54 mdx mice 54 cerebral perfusion 54 plasma cortisol 54 3TC lamivudine Epivir 54 cardiac dysfunction 54 sinus rhythm 54 HepG2 cells 54 liver biopsies 54 LPV r 54 coinfected patients 54 prolactin levels 54 leucopenia 54 anemia neutropenia 54 uPA 54 adriamycin 54 HOMA IR 54 mitomycin C 54 CP CPPS 54 immunomodulatory therapy 54 dalteparin 54 ribavirin therapy 54 Index CDAI 54 neurologic symptoms 54 ventricular dysfunction 54 reflux symptoms 54 anemia thrombocytopenia 54 fetal malformations 54 Stent thrombosis 54 amisulpride 54 μg ml 54 HBV infections 54 malignant phenotype 54 serum antibody 54 HIV uninfected 54 immune reconstitution 53 concomitant AEDs 53 hyperinsulinemia 53 Pegylated Interferon 53 adrenal insufficiency 53 postop 53 rFSH 53 ischemic mitral regurgitation 53 pelvic lymphadenectomy 53 epithelial tumors 53 desvenlafaxine succinate 53 endometrial thickness 53 antiphospholipid antibodies 53 nadroparin 53 AVODART 53 urinary albumin 53 BH4 53 hyperglycaemic 53 gastric carcinoma 53 bronchoalveolar lavage 53 conventional DMARDs 53 mitochondrial membrane potential 53 palivizumab 53 P cadherin 53 antiarrhythmic drug 53 tumor perfusion 53 natriuretic peptides 53 MADRS score 53 endoleak 53 postmenopausal estrogen 53 latent tuberculosis infection 53 ganciclovir 53 HBeAg negative 53 Immune responses 53 adenoma recurrence 53 serum sodium levels 53 gastric carcinogenesis 53 tumor histology 53 bilirubin levels 53 airway hyperresponsiveness 53 albumin excretion 53 tumorigenicity 53 pulmonary capillary wedge 53 corticospinal 53 TPV r 53 depressive symptomatology 53 QTc 53 hypoglycemic episodes 53 imipenem 53 recurrent UTI 53 cytotoxic effects 53 induced sputum 53 VEGF induced 53 hours postdose 53 syncope fainting 53 myocyte 53 EpCAM expression 53 nadolol 53 leukemic cell 53 basal cell nevus syndrome 53 Neutropenia 53 mycophenolate mofetil 53 plasma triglycerides 53 upper gastrointestinal bleeding 53 plasma folate 53 hsCRP levels 53 transgenic rats 53 doxorubicin docetaxel 53 iNOS 53 lesional 53 hyperreflexia 53 chronic HBV 53 demethylation 53 cardiac repolarization 53 creatine kinase 53 ICD shocks 53 chlamydial infection 53 serum calcium levels 53 salmeterol fluticasone 53 myocardial contractility 53 Vacc 4x 53 interferon IFN 53 mm ³ 53 acute gout flares 53 severe neutropenia 53 dopamine D2 receptor 53 CDI recurrence 53 hepatic arterial 53 concomitant medications 53 MMP2 53 H. pylori infection 53 dyssynchrony 53 atherothrombotic 53 annualized relapse 53 anakinra 53 Nilotinib 53 locoregional disease 53 spirometric 53 cART 53 CI -#.# 53 serum IgE 53 dosing interval 53 mucosal healing 53 glycosylated hemoglobin levels 53 tamoxifen Nolvadex ® 53 subclinical disease 53 acute ischemia 53 neovascularization 53 leukoencephalopathy 53 detrusor overactivity 53 rilpivirine 53 antiplatelet medication 53 paroxysmal atrial fibrillation 53 tardive dyskinesia TD 53 CD8 cell 53 adjuvant radiotherapy 53 HAART regimen 53 HCV infected 53 complete cytogenetic 53 node metastases 53 cardiac autonomic 53 serum IgG 53 viral loads 53 sitaxsentan 53 hypothalamic pituitary axis 53 extraocular 53 darunavir r 53 refractory gout 53 BCG vaccinated 53 acute decompensation 53 FasL 53 Severity Index PASI 53 enterococcal 53 Virologic 53 repolarization 53 CTGF 53 recurrent miscarriage 53 protein excretion 53 interferon beta therapy 53 decompensated cirrhosis 53 HCV replicon 53 antiviral therapy 53 mIU ml 53 transdermal estradiol 53 p = #.# [003] 53 candidemia 53 glomerular 53 undetectable hepatitis C 53 PANSS total 53 metastatic malignant melanoma 53 nephrotoxic drugs 53 fosamprenavir 53 canakinumab 53 CIN2 + 53 lymphocytic 53 leukemia ALL 53 elevated prolactin 53 metastatic uveal melanoma 53 antiviral efficacy 53 hypothalamic pituitary adrenal axis 53 flutamide 53 neuroregenerative 53 titratable 53 EDARBI 53 IgE mediated